WS #12015
Holding: newest synthesis is 129d 1h old
FDA approves subcutaneous version of Biogen's Leqembi for Alzheimer's, enabling at-home use and potentially boosting BIIB.
Biogen Leqembi Approval
FDA approves subcutaneous version of Biogen's Leqembi for Alzheimer's, enabling at-home use and potentially boosting BIIB.